Karyopharm Therapeutics (KPTI) Amortizatization of Intangibles (2016 - 2025)
Karyopharm Therapeutics' Amortizatization of Intangibles history spans 11 years, with the latest figure at $9000.0 for Q4 2025.
- For Q4 2025, Amortizatization of Intangibles fell 97.7% year-over-year to $9000.0; the TTM value through Dec 2025 reached $410000.0, down 83.63%, while the annual FY2025 figure was $410000.0, 83.63% down from the prior year.
- Amortizatization of Intangibles reached $9000.0 in Q4 2025 per KPTI's latest filing, down from $45000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.1 million in Q1 2023 to a low of -$664000.0 in Q1 2021.
- Average Amortizatization of Intangibles over 5 years is $313850.0, with a median of $263000.0 recorded in 2022.
- Peak YoY movement for Amortizatization of Intangibles: tumbled 5433.33% in 2021, then skyrocketed 2602.22% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$138000.0 in 2021, then skyrocketed by 436.23% to $464000.0 in 2022, then surged by 120.04% to $1.0 million in 2023, then plummeted by 61.61% to $392000.0 in 2024, then plummeted by 97.7% to $9000.0 in 2025.
- Per Business Quant, the three most recent readings for KPTI's Amortizatization of Intangibles are $9000.0 (Q4 2025), $45000.0 (Q3 2025), and $120000.0 (Q2 2025).